超越传统控制:对耐药高血压的洞察力
Pratyaksh Chhabra1, Rajoshee R Dutta1, Prerna Sahu1
1Medicine and Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Cureus
|September 18, 2023
概括
抗性高血压影响9-18%的高血压患者,增加心血管风险. 有效的管理需要了解其原因,诊断和治疗,包括改变生活方式和先进疗法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 抗性高血压 (RH) 影响9-18%的高血压患者,造成显著的心血管风险.
- 准确的诊断和管理对于患有RH的患者至关重要.
- 了解不同的病因,风险因素和并发症对于RH治疗决策至关重要.
研究的目的:
- 审查抗性高血压的流行病学,危险因素,原因和病原性.
- 概述诊断策略,以识别抗性高血压.
- 总结当前和新兴的抗性高血压治疗方法.
主要方法:
- 对流行病学数据,临床研究和耐药高血压治疗指南的文献综述.
- 诊断标准和差异诊断的分析,包括伪高血压和白衣高血压.
- 评估药理和干预治疗选择,包括改变生活方式和新疗法.
主要成果:
- 抗性高血压是指尽管服用了三种或以上的抗高血压药物,包括利尿剂,但血压仍无法控制.
- 有效的多种药物治疗方案包括ACE抑制剂,ARBs,β-抑制剂,利尿剂,CCBs和MRAs.
- 新兴的治疗方法,如脏缩和巴罗反射激活,显示出降低血压的前景.
- 必须调查睡眠呼吸暂停,心血管,脏和内分泌疾病等二次原因.
结论:
- 为了诊断和管理抗性高血压,需要进行全面的评估.
- 治疗需要多方面的方法,包括改变生活方式,药物治疗和潜在的干预程序.
- 对新型疗法的进一步研究对于改善耐高血压患者的长期结果至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
Antihypertensive Drugs: Direct Renin Inhibitors
677
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
677
Hypertension III: Clinical Manifestations and Diagnostic Studies
25
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
25
Hypertension IV: Drug Therapy and Lifestyle Modifications
13
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
13
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
776
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
776


